Arkadios Wealth Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
13,356
+559
+4% +$57.9K 0.02% 687
2026
Q1
$1.24M Buy
12,797
+1,102
+9% +$113K 0.02% 692
2025
Q4
$1.24M Buy
11,695
+597
+5% +$69.2K 0.02% 612
2025
Q3
$1.41M Buy
11,098
+2,318
+26% +$276K 0.03% 516
2025
Q2
$1.08M Sell
8,780
-463
-5% -$52.9K 0.03% 541
2025
Q1
$936K Buy
+9,243
New +$902K 0.04% 482
2021
Q1
Sell
-268
Closed -$17K 1664
2020
Q4
$17K Sell
268
-15
-5% -$882 ﹤0.01% 799
2020
Q3
$15.3K Sell
283
-6
-2% -$308 0.01% 657
2020
Q2
$14.4K Sell
289
-244
-46% -$13.2K 0.01% 611
2020
Q1
$27.1K Sell
533
-41
-7% -$2.36K 0.02% 431
2019
Q4
$37.6K Buy
+574
New +$31.1K 0.02% 351

Other funds holding EHC

Arkadios Wealth Advisors's EHC Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its Encompass Health (EHC) stake by 4.4% in Q2 2026, buying an estimated $57.9K and bringing the position to 13,356 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #687.

Arkadios Wealth Advisors first reported a position in EHC in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.41M in Q3 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Arkadios Wealth Advisors held 13,356 shares of Encompass Health worth $1.35M as of Q2 2026.
  • Arkadios Wealth Advisors bought 559 Encompass Health shares in Q2 2026, an estimated $57.9K.
  • Encompass Health made up 0.02% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #687 holding.
  • Arkadios Wealth Advisors first reported a position in Encompass Health in Q4 2019 and has held it in 11 quarters since.
  • Arkadios Wealth Advisors's Encompass Health position peaked at $1.41M in Q3 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.